Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Efforts underway to develop trypanosomiasis test
The parasite is an emerging serious threat in countries like South Africa, where more than 20 per cent of the global cattle population is farmed.
Common parasite infection causes three million cattle deaths annually. 

Scientists at the University of Edinburgh's Roslin Institute are seeking to develop a diagnostic test for the common parasite infection, trypanosomiasis – a disease that affects communities and livestock in some of the world's poorest regions.

Working with agri-tech firm Roslin Technologies, researchers aim to develop a test that could prevent infected animals from severe anaemia and wasting. Spread by the tsetse fly, the disease impacts milk and meat yields, causing an estimated three million cattle deaths every year.

Dr Finn Grey from the Roslin Institute said: “This parasite-borne disease is a serious concern for livestock and affected communities. Tackling it is a key step towards ensuring food security and supporting people in affected regions.”

Researchers say the test will be based on the detection of RNA, a small molecule of genetic material. RNA can also be used to differentiate between different trypanosome species.

The project will take 12 months, during which researchers will develop and validate the test, including assessing its sensitivity and ability to detect particular parasite species. It will then be handed over to Roslin Technologies for scale-up, kit development and preparation.

Professor Jacqui Matthews from Roslin Technologies, said: “We are very pleased to be working with the University of Edinburgh team to take this much-needed test to the next stage in its commercial development.”

Current trypanosomiasis tests can be ineffective in identifying animals with active infections. This can result in the over-use of anti-parasitic drugs, accelerating drug resistance among the parasites and make treatments less effective.

With no vaccine to protect against trypanosomiasis, control of the disease is centred on identifying and treating the affected animals. The parasite is an emerging serious threat in countries such as South America, where more than 20 per cent of the global cattle population is farmed.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.